What is LiQure?
LiQure operates at the intersection of nutraceuticals and consumer wellness, providing a specialized line of gummies engineered to mitigate the physiological impact of alcohol consumption. By leveraging a proprietary blend of vitamins, botanical extracts, and dihydromyricetin (DHM), the company facilitates efficient alcohol metabolism and essential nutrient restoration. The brand distinguishes itself through a clean-label commitment, ensuring all products are gluten-free, non-GMO, and devoid of synthetic additives. This strategic focus on liver health and metabolic support positions LiQure as a high-growth player in the rapidly expanding functional food and beverage landscape, catering to a demographic that prioritizes health-conscious recovery solutions.
How much funding has LiQure raised?
LiQure has raised a total of $250K across 1 funding round:
Stock/Share Issuance
$250K
Stock/Share Issuance (2026): $250K, investors not publicly disclosed
Key Investors in LiQure
Undisclosed Investors
Undisclosed Investors
Undisclosed Investors
What's next for LiQure?
With this late-stage financing, LiQure is poised to scale its operational infrastructure and expand its distribution footprint. The capital will likely be deployed toward enhancing supply chain resilience, scaling manufacturing capabilities to meet rising consumer demand, and intensifying research and development efforts to broaden its product portfolio. As the company transitions into this next phase of maturity, the focus will shift toward establishing dominant market share and exploring international expansion opportunities. The strategic backing provides the necessary liquidity to navigate competitive pressures while maintaining the brand's commitment to high-quality, science-backed wellness solutions.
See full LiQure company page
